Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET
European Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.1007/s00259-024-06654-5 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Lena Kaiser und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Lena.Kaiser@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Receptors, GABA, Isocitrate Dehydrogenase, Mutation, Positron-Emission Tomography. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universitätsklinik München.
Abstract (Originalsprache)
Purpose
According to the World Health Organization classification for tumors of the central nervous system, mutation status of the isocitrate dehydrogenase ( IDH ) genes has become a major diagnostic discriminator for gliomas. Therefore, imaging-based prediction of IDH mutation status is of high interest for individual patient management. We compared and evaluated the diagnostic value of radiomics derived from dual positron emission tomography (PET) and magnetic resonance imaging (MRI) data to predict the IDH mutation status non-invasively.
Methods
Eighty-seven glioma patients at initial diagnosis who underwent PET targeting the translocator protein (TSPO) using [ 18 F]GE-180, dynamic amino acid PET using [ 18 F]FET, and T1-/T2-weighted MRI scans were examined. In addition to calculating tumor-to-background ratio (TBR) images for all modalities, parametric images quantifying dynamic [ 18 F]FET PET information were generated. Radiomic features were extracted from TBR and parametric images. The area under the receiver operating characteristic curve (AUC) was employed to assess the performance of logistic regression (LR) classifiers. To report robust estimates, nested cross-validation with five folds and 50 repeats was applied.
Results
TBR GE-180 features extracted from TSPO-positive volumes had the highest predictive power among TBR images (AUC 0.88, with age as co-factor 0.94). Dynamic [ 18 F]FET PET reached a similarly high performance (0.94, with age 0.96). The highest LR coefficients in multimodal analyses included TBR GE-180 features, parameters from kinetic and early static [ 18 F]FET PET images, age, and the features from TBR T2 images such as the kurtosis (0.97).
Conclusion
The findings suggest that incorporating TBR GE-180 features along with kinetic information from dynamic [ 18 F]FET PET, kurtosis from TBR T2 , and age can yield very high predictability of IDH mutation status, thus potentially improving early patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Lena.Kaiser@med.uni-muenchen.de.
- Department of Neurosurgery, University Hospital, LMU Munich, 81377, Munich, Germany.
- Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
- Department of Neuroradiology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
- Bavarian Cancer Research Center (BZKF), 91054, Erlangen, Germany.
- German Center for Neurodegenerative Diseases (DZNE), 81377, Munich, Germany.
ORCID-Profile: Lena Kaiser
Förderung
- Deutsche Forschungsgemeinschaft
- Universitätsklinik München
Zitieren
APA
Kaiser, L., Quach, S., Zounek, A. J., Wiestler, B., Zatcepin, A., Holzgreve, A., Bollenbacher, A., Bartos, L. M., Ruf, V. C., Böning, G., Thon, N., Herms, J., Riemenschneider, M. J., Stöcklein, S., Brendel, M., Rupprecht, R., Tonn, J. C., Bartenstein, P., von Baumgarten, L., …, & Albert, N. L. (2024). Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06654-5
Vancouver
Kaiser L, Quach S, Zounek AJ, Wiestler B, Zatcepin A, Holzgreve A, et al. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06654-5
BibTeX
@article{Kaiser2024,
author = {Kaiser, Lena and Quach, S and Zounek, A J and Wiestler, B and Zatcepin, A and Holzgreve, A and Bollenbacher, A and Bartos, L M and Ruf, V C and Böning, G and Thon, N and Herms, J and Riemenschneider, M J and Stöcklein, S and Brendel, M and Rupprecht, R and Tonn, J C and Bartenstein, P and von Baumgarten, L and Ziegler, S and Albert, N L},
title = {Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.1007/s00259-024-06654-5}
}
EUVIMED